Cowen analyst Ritu Baral initiates coverage on AN2 Therapeutics (NASDAQ: ANTX) with an Outperform rating.The analyst commented, "We are initiating ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE